These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 2886133)
1. High-dose clonidine motor syndrome: relationship to serotonin syndrome. Pranzatelli MR; Schultz L; Snodgrass SR Behav Brain Res; 1987 Jun; 24(3):221-32. PubMed ID: 2886133 [TBL] [Abstract][Full Text] [Related]
2. Serotonin-lesion myoclonic syndromes. II. Analysis of individual syndrome elements, locomotor activity and behavioral correlations. Pranzatelli MR; Snodgrass SR Brain Res; 1986 Jan; 364(1):67-76. PubMed ID: 3484993 [TBL] [Abstract][Full Text] [Related]
3. Effects of 5-HT receptor subtype-selective drugs on locomotor activity and motor habituation in the DHT adult rat model. Pranzatelli MR; Jappay E; Snodgrass SR Pharmacol Biochem Behav; 1987 Jul; 27(3):497-504. PubMed ID: 3116560 [TBL] [Abstract][Full Text] [Related]
4. Enhanced selective 5-HT depletions in the DHT rat model: denervation supersensitivity and recovery of function. Pranzatelli MR; Snodgrass SR Psychopharmacology (Berl); 1986; 89(4):449-55. PubMed ID: 3092275 [TBL] [Abstract][Full Text] [Related]
5. The comparative pharmacology of the behavioral syndromes induced by TRH and by 5-HT in the rat. Pranzatelli MR Gen Pharmacol; 1988; 19(2):205-11. PubMed ID: 2895033 [TBL] [Abstract][Full Text] [Related]
6. Functional subsensitivity of 5-hydroxytryptamine1C or alpha 2 adrenergic heteroreceptors mediating clonidine-induced growth hormone release in the Fawn-Hooded rat strain relative to the Wistar rat strain. Aulakh CS; Hill JL; Lesch KP; Murphy DL J Pharmacol Exp Ther; 1992 Sep; 262(3):1038-43. PubMed ID: 1356149 [TBL] [Abstract][Full Text] [Related]
7. The effects of lesions produced by 5,7-dihydroxytryptamine on 5-hydroxytryptamine-mediated behaviour induced by amphetamine in large doses in the rat. Dickinson SL; Andrews CD; Curzon G Neuropharmacology; 1984 Apr; 23(4):423-9. PubMed ID: 6728129 [TBL] [Abstract][Full Text] [Related]
8. Acute and subchronic effects of methylenedioxymethamphetamine [(+/-)MDMA] on locomotion and serotonin syndrome behavior in the rat. Spanos LJ; Yamamoto BK Pharmacol Biochem Behav; 1989 Apr; 32(4):835-40. PubMed ID: 2572003 [TBL] [Abstract][Full Text] [Related]
9. Prevention of reserpine rigidity by alpha-2 adrenergic antagonists. Wagner BH; Anderson RJ Pharmacol Biochem Behav; 1982 May; 16(5):731-5. PubMed ID: 6124006 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of clonidine, B-HT 933 and B-HT 920 in immature rat pups. Goodlett CR; Valentino ML Pharmacol Biochem Behav; 1987 Jun; 27(2):283-90. PubMed ID: 2819900 [TBL] [Abstract][Full Text] [Related]
11. The functional significance of neonatal 5,7-dihydroxytryptamine lesions in the rat: response to selective 5-HT1A and 5-HT2,1C agonists. Pranzatelli MR; Dollison AM; Huang YY Brain Res Bull; 1990 Jun; 24(6):747-53. PubMed ID: 2142615 [TBL] [Abstract][Full Text] [Related]
12. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine. Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387 [TBL] [Abstract][Full Text] [Related]
13. Clonidine-induced locomotor hyperactivity in rats. The role of central postsynaptic alpha-adrenoceptors. Zebrowska-Lupina I; Przegalinski E; Sloniec M; Kleinrok Z Naunyn Schmiedebergs Arch Pharmacol; 1977 Apr; 297(3):227-31. PubMed ID: 69273 [TBL] [Abstract][Full Text] [Related]
14. Effects of spinal alpha(2)-adrenoceptor and I(1)-imidazoline receptor activation on hindlimb movement induction in spinal cord-injured mice. Lapointe NP; Ung RV; Rouleau P; Guertin PA J Pharmacol Exp Ther; 2008 Jun; 325(3):994-1006. PubMed ID: 18364473 [TBL] [Abstract][Full Text] [Related]
15. Behavioral evidence for supersensitivity following destruction of central serotonergic nerve terminals by 5,7-dihydroxytryptamine. Trulson ME; Eubanks EE; Jacobs BL J Pharmacol Exp Ther; 1976 Jul; 198(1):23-32. PubMed ID: 132525 [TBL] [Abstract][Full Text] [Related]
16. In vivo electrophysiological evidence for tonic activation by endogenous noradrenaline of alpha 2-adrenoceptors on 5-hydroxytryptamine terminals in the rat hippocampus. Mongeau R; Blier P; de Montigny C Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):266-72. PubMed ID: 8097564 [TBL] [Abstract][Full Text] [Related]
17. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats. Fone KC; Johnson JV; Bennett GW; Marsden CA Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455 [TBL] [Abstract][Full Text] [Related]
18. S18616, a highly potent spiroimidazoline agonist at alpha(2)-adrenoceptors: II. Influence on monoaminergic transmission, motor function, and anxiety in comparison with dexmedetomidine and clonidine. Millan MJ; Lejeune F; Gobert A; Brocco M; Auclair A; Bosc C; Rivet JM; Lacoste JM; Cordi A; Dekeyne A J Pharmacol Exp Ther; 2000 Dec; 295(3):1206-22. PubMed ID: 11082458 [TBL] [Abstract][Full Text] [Related]